---
title: "Prostate cancer: Symptoms & Treatment | HealthAnswers"
description: "Prostate cancer — symptoms, PSA testing, diagnosis, staging, and NHS treatment options explained in plain English."
url: https://healthanswers.co.uk/conditions/prostate-cancer/
robots: noindex
---

# Prostate cancer: Symptoms & Treatment | HealthAnswers

Health A–Z

Prostate cancer — symptoms, PSA testing, diagnosis, staging, and NHS treatment options explained in plain English.

Written by HealthAnswers editorial team Medically reviewed by [HealthAnswers UK doctor review panel](https://healthanswers.co.uk/our-doctors/) Reviewed 3 July 2026

## Quick answer

What is prostate cancer? Prostate cancer is the most common cancer in UK men — often slow-growing and confined to the prostate when found. Early disease may have no symptoms — urinary symptoms usually relate to benign enlargement not cancer. PSA blood test is offered with informed choice from age 50 — not a perfect screen. Diagnosis requires MRI and biopsy. Treatment ranges from active surveillance for low-risk disease to surgery, radiotherapy, or hormone therapy for higher risk.

## Who is this page for?

This page is for people in the UK who want a plain-English overview of Prostate cancer, including when to seek help and what NHS care usually involves. It explains general information, not what is wrong with you personally.

## Who should skip this page?

Skip this page if you need a diagnosis, a prescription, or emergency care. It cannot replace a GP, pharmacist, NHS 111 or 999. If you are in immediate danger, call 999; for urgent advice that is not life-threatening, call 111 in England, Scotland or Wales, or use your GP out-of-hours service in Northern Ireland.

On this page 8 sections

## Key facts about prostate cancer

- About 1 in 8 men get prostate cancer — more common in Black Caribbean and African men who should consider PSA discussion from 45.
- Early prostate cancer often has no symptoms — urinary problems usually due to benign enlarged prostate (BPH).
- PSA test measures prostate specific antigen — raised in cancer but also BPH, prostatitis, and after ejaculation.
- mpMRI before biopsy improves detection and reduces unnecessary biopsies — standard NHS pathway.
- Low-risk cancer may be monitored with active surveillance — avoiding overtreatment side effects.

## Prostate cancer — what men need to know

**Prostate cancer** is the **most common cancer in UK men** — **~52,000 cases yearly** — **1 in 8 lifetime risk**. **Black men** — **1 in 4** — **discuss PSA from 45**.

Most diagnosed men **live many years** — **slow-growing disease common** — but **aggressive subtypes** exist — **reason for informed screening debate**.

## Prostate gland basics

Walnut-sized — below bladder — surrounds urethra — **PSA** protein leaks into blood from **normal and cancerous** tissue.

**Urinary symptoms** — usually **[BPH](https://healthanswers.co.uk/conditions/enlarged-prostate/)** not cancer — but **assessment overlaps**.

## Symptoms

**Localised (early):**

- often none

**Locally advanced:**

- urinary frequency , hesitancy — overlap BPH

- haematuria , haematospermia

- ED

**Metastatic:**

- bone pain — spine, hips

- weight loss , fatigue

- spinal cord compression — emergency

## PSA testing — informed choice

**Not UK population screen** — **man chooses after GP discussion**:

**Pros:**

- finds curable localised cancer

**Cons:**

- false positives — biopsy anxiety

- overdiagnosis — slow cancers never harmful

- false negatives

**Offer from 50** — **45 Black ethnicity or family history** (father/brother <65)

**Before test:** avoid **ejaculation, vigorous exercise, cycling 48h**, **UTI**, **recent biopsy** — can skew PSA.

## Diagnostic pathway

- PSA + DRE (digital rectal exam)

- Repeat PSA if borderline

- mpMRI prostate — before biopsy standard

- Biopsy — transperineal preferred — Gleason grade , volume

- Staging — bone scan/PSMA PET selected metastatic workup

**Risk groups:** low, intermediate, high, locally advanced, metastatic — **guides treatment**.

## Treatment options

### Low risk — active surveillance

**Monitor PSA, MRI, repeat biopsy** — **avoid overtreatment harm** — **~40%** progress eventually need treatment.

### Curative intent localised

- radical prostatectomy — robotic laparoscopic common

- external beam radiotherapy ± short hormone

- brachytherapy — radioactive seeds

**Side effects:** **incontinence**, **ED** — **nerve-sparing** reduces — **discuss upfront**.

### High risk / locally advanced

- radiotherapy + long-term ADT (androgen deprivation therapy)

- surgery selected

### Metastatic

- long-term hormone therapy — LHRH agonists/antagonists

- abiraterone, enzalutamide, apalutamide

- docetaxel , ** cabazitaxel**

- radiotherapy to primary — STAMPEDE trial benefit some

**Not curable** but **controllable years to decade+**.

## Living with prostate cancer

**Prostate Cancer UK** — **Specialist Nurses**

**Support groups**, ** erectile rehabilitation**, **pelvic floor physio**

## Prevention — limited evidence

- healthy weight

- tomato-rich diet / lycopene — weak association

- no proven prevention drug for general population

**Know your risk** — **PSA conversation**, not **PSA fear** or **PSA avoidance by default**.

**Raised PSA is gateway to MRI** — **not automatic cancer sentence**.

## ! When to see a GP about prostate cancer

Discuss PSA testing from 50 (45 if Black or family history of prostate cancer under 65) — understand pros and cons before blood test. See a GP for urinary symptoms — weak stream, blood in urine — usually BPH but needs assessment. 2-week wait referral if prostate feels abnormal on examination or PSA significantly elevated with suspicious MRI.

## Common questions about prostate cancer

What are the symptoms of prostate cancer? Early localised cancer — often no symptoms. Advanced disease — urinary problems (though BPH more common cause), blood in urine or semen, erectile dysfunction, hip or back pain from bone spread. Do not wait for symptoms — consider PSA discussion age-appropriately. Should I have a PSA test? Informed choice from 50 (45 high-risk groups) — PSA can be raised without cancer causing anxiety and biopsies; may miss some cancers; detects slow-growing disease that might never harm. Benefits include finding aggressive cancers early when curable. GP explains before testing. What happens if PSA is raised? Repeat PSA, examination, referral to urology — multiparametric MRI (mpMRI) prostate — PI-RADS scoring — targeted biopsy if suspicious. Transperineal biopsy now common — reduced infection risk vs transrectal. How is prostate cancer treated? Depends on risk group — active surveillance (monitor low risk), radical prostatectomy (surgery), external beam radiotherapy, brachytherapy (seed implant), hormone therapy (androgen deprivation) for advanced or high-risk, chemotherapy or newer agents for metastatic disease. Side effects include urinary incontinence and erectile dysfunction — discuss upfront. Is prostate cancer curable? Localised disease — high cure rates with surgery or radiotherapy. Metastatic disease — not usually curable but controllable for years with hormone therapy and newer drugs (abiraterone, enzalutamide). Many men die with prostate cancer not from it — especially low-grade disease. What is the difference between prostate cancer and enlarged prostate? BPH (benign prostatic hyperplasia) — urinary symptoms from non-cancerous growth — extremely common. Prostate cancer arises from glandular cells — may coexist — PSA and examination cannot fully distinguish — MRI and biopsy required if cancer suspected.

## Sources

- [NHS — Prostate cancer](https://www.nhs.uk/conditions/prostate-cancer/)
- [Prostate Cancer UK](https://prostatecanceruk.org/)
- [NICE — Prostate cancer](https://www.nice.org.uk/guidance/ng131)